Table 4.
Baseline characteristics of TRIUMPH patients
| Characteristics | All n=4340 |
White n=3022 |
Non-White n=1305 |
p-value |
|---|---|---|---|---|
| Sociodemographics | ||||
| Age (years) | 59.1±12.3 | 59.9±12.3 | 57.1±12.2 | <0.001 |
| Male | 67% | 71% | 58% | <0.001 |
| White | 70% | |||
| Married | 51% | 59% | 33% | <0.001 |
| No insurance | 21% | 18% | 34% | <0.001 |
| High school education | 79% | 85% | 67% | <0.001 |
| Clinical factors | ||||
| ST-elevations on admission | 43% | 48% | 32% | <0.001 |
| Hypertension | 67% | 62% | 78% | <0.001 |
| Prior MI | 21% | 20% | 24% | 0.005 |
| Prior PCI | 20% | 20% | 18% | 0.062 |
| Prior heart failure | 9% | 6% | 15% | <0.001 |
| Diabetes | 31% | 27% | 40% | <0.001 |
| Family history of heart disease | 74% | 79% | 63% | <0.001 |
| Dyslipidemia | 49% | 51% | 44% | <0.001 |
| Chronic kidney disease | 7% | 5% | 13% | <0.001 |
| Chronic lung disease | 7% | 7% | 8% | 0.73 |
| History of smoking | 59% | 59% | 60% | 0.93 |
| Body mass index (kg/m2) | 29.5±6.5 | 29.4±6.1 | 29.8±7.3 | 0.12 |
| Disease severity | ||||
| Systolic blood pressure (mmHg) | 143±30 | 141±30 | 148±31 | <0.001 |
| Diastolic blood pressure (mmHg) | 83±19 | 82±19 | 86±19 | <0.001 |
| Heart rate on admission (bpm) | 83±22 | 82±23 | 85±21 | <0.001 |
| Ejection fraction (%) | 49±13 | 49±12 | 48±15 | 0.018 |
| Peak troponin level (ng/mL) | 29±73 | 33±73 | 19±65 | <0.001 |
| Initial creatinine level (mg/dL) | 1.2±1.1 | 1.2±0.8 | 1.5±1.6 | <0.001 |
| Initial hemoglobin level (g/dL) | 14.0±2.1 | 14.3±2 | 13.3±2.3 | <0.001 |
| Hs-CRP level (mg/L) | 3.7±5.0 | 3.7±4.9 | 3.6±5.3 | 0.51 |
| LDL level (mg/dL) | 95±32 | 95±31 | 96±35 | 0.51 |
| GRACE score for 6 -month mortality56 | 101±30 | 101±30 | 100±30 | 0.39 |
| Hospital procedures | ||||
| Coronary angiography | 92% | 95% | 85% | <0.001 |
| Primary PCI | 34% | 38% | 26% | <0.001 |
| Nonprimary PCI | 29% | 32% | 24% | <0.001 |
| Coronary bypass surgery | 9% | 10% | 8% | 0.007 |
| Quality performance measures* | ||||
| Aspirin within 24 hours | 97% | 98% | 97% | 0.47 |
| Aspirin at discharge | 95% | 96% | 94% | <0.001 |
| ACE-I/ARB for left ventricular systolic dysfunction | 85% | 87% | 83% | 0.17 |
| Smoking cessation counseling | 75% | 80% | 66% | <0.001 |
| Beta-blocker at discharge | 93% | 95% | 90% | <0.001 |
| Fibrinolytics by 30 min or primary PCI by 90 min | 52% | 58% | 40% | <0.001 |
| In-hospital outcomes | ||||
| Mortality | 0.6% | 0.5% | 0.7% | 0.43 |
| Length of stay (days) | 5.7±7.0 | 5.5±7.2 | 6.1±6.3 | 0.007 |
Abbreviations: MI=myocardial infarction; PCI=percutaneous coronary intervention; Hs-CRP=high sensitivity C-reactive protein; LDL=low density lipoprotein; ACE-I=angiotensin converting enzyme-inhibitor; ARB=angiotensin receptor blocker
*
For those eligible